Ksea
Country not established
- Devices
- 1
What Ksea makes
Ksea manufactures the KSEA Bipolar Electrotome, a device designed for precise tissue ablation or coagulation in surgical procedures, typically used in orthopedic or arthroscopic applications.
The company’s portfolio is regulated under FDA Class II devices, with the KSEA Bipolar Electrotome authorised via the 510(k) clearance pathway. The device is listed in the FDA’s 510(k) registry. Ksea is based in the United States.
Catalogue
Ksea Bipolar Electrotome Ref K061541
510(k) 510(k)
Frequently asked questions
How many devices does Ksea have in the registry?
The registry currently lists 1 device for Ksea. Devices recorded under merged duplicate company entries are counted once.
Which registries list Ksea's devices?
Among its 1 most recently registered device, Ksea has devices listed in FDA 510(k) (1 device).
What risk classes do Ksea's devices fall under?
Among its 1 most recently registered device, the classes recorded for Ksea's devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Ksea in the registry?
The most recently registered devices listed for Ksea include KSEA BIPOLAR ELECTROTOME.